🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Glaucoma is the second most common blindness disease in the world, second o...
Status
Unknown
Location
Zhognshan Ophthalmic Center, Sun Yat-sen University
Start Date
2021-11-07
Trial ID
NCT05130554
Treatments Being Tested
Trabeculectomy and XEN45 gel stent implantation are glaucoma surgeries that...
Status
Completed
Location
Hospital Clínic - ICOF
Start Date
2021-01-01
Trial ID
NCT04727411
Treatments Being Tested
The objective of this study is to evaluate the change of endothelial cell c...
Status
Completed
Location
Dept. Ophthalmology and Optometry Paracelsus Medical University
Start Date
2020-01-30
Trial ID
NCT04547036
Treatments Being Tested
Purpose: To report the follow-up data for patients who had XEN45 gel stent ...
Status
Completed
Location
Multiple Locations
Start Date
2015-01
Trial ID
NCT03138928
Treatments Being Tested
The purpose of this study is to compare the safety and efficacy of XEN-45 t...
Status
Completed
Location
Vold Vision /ID# 233677
Start Date
2018-10-01
Trial ID
NCT03654885
Treatments Being Tested
Glaucoma is the second most common cause of blindness in the world, second ...
Status
Completed
Location
Vold Vision /ID# 245285
Start Date
2022-07-22
Trial ID
NCT05411198
Treatments Being Tested
The Xen implant is an ab interno device that has been shown to be effective...
Status
Completed
Location
Sara Pose-Bazarra
Start Date
2018-01-01
Trial ID
NCT06993311
Treatments Being Tested
The objective of this study was to evaluate the AqueSys XEN Implant \[XEN® ...
Status
Completed
Location
University of Graz
Start Date
2013-12-05
Trial ID
NCT02006693
Treatments Being Tested
A retrospective, non-interventional, observational, multi-center, chart rev...
Status
Completed
Location
Clinical Trials Registry Team
Start Date
2019-04-05
Trial ID
NCT03868254
Treatments Being Tested